SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA (MM) REFRACTORY TO PROTEASOME INHIBITORS, IMMUNOMODULATORS, AND ANTI-CD38
Por:
Ricos, GG, Sabater, LA, Fernandez, G, Sarto, MF, Gomez, MS, Giro, EC, Escoda, MC, Perez, AE, Montes, CD, Mas, M, Vilchez, DQ, Ribera-Santasusana, JM and Rocafiguera, AO
Publicada:
21 oct 2019
Categoría:
Hematology
Resumen:
Filiaciones:
Ricos, GG:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Sarto, MF:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Gomez, MS:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Giro, EC:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Escoda, MC:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Perez, AE:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Montes, CD:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Mas, M:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Vilchez, DQ:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
|